Your browser doesn't support javascript.
loading
Active components and mechanisms of total flavonoids from Rhizoma Drynariae in enhancing cranial bone regeneration: An investigation employing serum pharmacochemistry and network pharmacology approaches.
Zhao, Yuxiao; Cai, Xiaofang; Sun, Jian; Bi, Wei; Yu, Youcheng.
Afiliação
  • Zhao Y; Department of Stomatology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, PR China.
  • Cai X; Department of Stomatology, Minhang Hospital, Fudan University, No. 170 Xinsong Road, Shanghai, 201199, PR China.
  • Sun J; Department of Stomatology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, PR China.
  • Bi W; Department of Stomatology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, PR China.
  • Yu Y; Department of Stomatology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, PR China. Electronic address: yu.youcheng@zs-hospital.sh.cn.
J Ethnopharmacol ; 319(Pt 3): 117253, 2024 Jan 30.
Article em En | MEDLINE | ID: mdl-37778522
ABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE Rhizoma Drynariae, as the dried rhizome of Drynaria fortunei (Kunze ex Mett.) J. Sm., is a traditional Chinese medicine for treating the injury and bone broken of falling and beating. Total flavonoids is considered as the major and effective compounds for the therapeutic efficacy of Rhizoma Drynariae. AIM OF THE STUDY To explore the effect of total flavonoids from Rhizoma Drynariae (TFRD) on bone regeneration and the underlying mechanisms. MATERIALS AND

METHODS:

The effect of TFRD in various doses on bone reconstruction in cranial bone defect rats was explored in vivo. The active ingredients in TFRD-medicated serum were characterized by serum pharmacochemistry and integrated by network pharmacology analysis and target prediction. To elucidate the underlying mechanism of TFRD on bone regeneration, experimental validation in vitro was executed to assess the influence of different concentrations of TFRD-medicated serum on osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).

RESULTS:

Micro-CT, histological examination, immunohistochemical analysis, and ELSA demonstrated that administration of TFRD could promote bone reconstruction in a rat cranial defect model. We identified 27 active components of TFRD using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS). Results from CCK8, ALP, and Alizarin Red S staining revealed that TFRD-medicated serum notably enhanced BMSCs proliferation and osteogenic differentiation. qRT-PCR and Western blot harvested results consistent with those predicted by network pharmacology, providing further evidence that TFRD activated the TGF-ß signaling pathway to benefit bone regeneration.

CONCLUSION:

The active components of TFRD modulate the TGF-ß signaling pathway to facilitate osteogenesis, thereby repairing cranial bone defects.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteogênese / Polypodiaceae Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Ethnopharmacol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteogênese / Polypodiaceae Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Ethnopharmacol Ano de publicação: 2024 Tipo de documento: Article